Check out our July Issue
Pharmacists have a relationship with their patients that other healthcare providers do not, and they are in a position to significantly affect disease-state management. » More
|
If state pharmacy boards, which are comprised of pharmacists, are in control of PBMs, the boards could act in favor of their own interests. » More
|
Pharmacists are often confronted with dosing drugs in an obese patient. Unfortunately, many clinical trials exclude or have limited overweight patients enrolled; thus, optimal dosing for both safety and efficacy in this population is lacking. » More
|
Mike Lahr, BS Pharm, PharmD, reflects on his career and the moments that affected him the most. » More
|
Less than a month after FDA warned of an outbreak following steroid injections from a compounding pharmacy there, the Tennessee Board of Pharmacy strengthened its oversight of compounding pharmacies. » More
|
|
|